Erratum to: Int J Hematol DOI 10.1007/s12185-016-2097-9
The authors would like to correct the errors in the publication of the original article. The corrected details are given below for your reading.
The Clinical trial number should be “UMIN000001603” at the end of Abstract and in the last sentence of the paragraph heading “Study design and patients” under “Materials and methods” section.
Secondly, the Fig. 1 was incorrectly published with the meaningless red font. The corrected figure is given below:
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s12185-016-2097-9.
About this article
Cite this article
Igarashi, T., Ogura, M., Itoh, K. et al. Erratum to: Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden. Int J Hematol 105, 109–110 (2017). https://doi.org/10.1007/s12185-016-2155-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-016-2155-3